Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.71B |
| Enterprise Value | 6.2B |
| P/E Ratio | 20.34 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 4.54 |
| Price/Book Ratio | 1.53 |
| Enterprise/Revenue | 4.05 |
| Enterprise/EBITDA | 18.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.23 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 1.06B |
| Revenue/Share | 3.31 |
| Gross Profit | 762.92M |
| EBITDA | 231.92M |
| Net Income | 244.37M |
| Diluted EPS | 0.76 |
Balance Sheet
| Total Cash | 1.73B |
| Total Cash/Share | 5.42 |
| Total Debt | 63.67M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.98 |
| Book Value Per Share | 10.11 |
Price History
| 52-Week Change | -4.84 |
| 52-Week High | 28 |
| 52-Week Low | 17.5 |
| Moving Average 50 Days | 21.44 |
| Moving Average 200 Days | 23.3 |
Statistics
| Average Volume | 673,254 |
| Shares Outstanding | 310.76M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.31 |
| Trailing Annual Dividend Yield | 2.02 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
